Literature DB >> 19542869

Complete hydatidiform mole with retained maternal chromosomes 6 and 11.

Thomas G McConnell1, Alexis Norris-Kirby, Jill M Hagenkord, Brigitte M Ronnett, Kathleen M Murphy.   

Abstract

Distinction of hydatidiform moles from nonmolar specimens and their subclassification as complete hydatidiform mole (CHM) versus partial hydatidiform mole (PHM) are important for clinical practice and investigational studies to refine ascertainment of risk of persistent gestational trophoblastic disease which differs among these entities. Immunohistochemical analysis of p57 expression, a paternally imprinted maternally expressed gene on 11p15.5, and molecular genotyping are useful for improving diagnosis. CHMs are characterized by androgenetic diploidy, with the loss of p57 expression owing to lack of maternal DNA. Loss of p57 expression distinguishes CHMs from both PHMs (diandric triploidy) and nonmolar specimens (biparental diploidy) which retain expression. In the process of evaluating molar specimens in our laboratory with p57 immunohistochemistry and molecular genotyping, we identified a morphologically typical androgenetic diploid CHM with aberrant diffuse p57 expression. Molecular genotyping by short tandem repeat markers and genome-wide copy number analysis by single nucleotide polymorphism array established androgenetic diploidy with retained maternal copies of chromosomes 6 and 11, with aberrant p57 expression attributable to the latter. This case, only the second reported to date, illustrates the value of combined traditional pathologic and ancillary molecular techniques for refined diagnosis of molar specimens. Specimens with morphologic features suggestive of CHM yet retaining p57 expression should be subjected to molecular genotyping to establish a definitive diagnosis because misclassification as PHM underestimates the risk of persistent gestational trophoblastic disease. We recommend use of p57 immunohistochemistry and molecular genotyping to evaluate all products of conception specimens for which there is any consideration of a diagnosis of hydatidiform mole. Genome-wide analysis has the potential to assist in localizing imprinted genes critical for determining the morphologic and behavioral phenotypes of hydatidiform moles.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19542869     DOI: 10.1097/PAS.0b013e3181a90e01

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  12 in total

1.  Abnormal villous morphology associated with triple trisomy of paternal origin.

Authors:  Alexis Norris-Kirby; Jill M Hagenkord; Malti P Kshirsagar; Brigitte M Ronnett; Kathleen M Murphy
Journal:  J Mol Diagn       Date:  2010-04-22       Impact factor: 5.568

2.  Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay.

Authors:  Kathleen M Murphy; Thomas G McConnell; Michael J Hafez; Russell Vang; Brigitte M Ronnett
Journal:  J Mol Diagn       Date:  2009-10-08       Impact factor: 5.568

3.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.

Authors:  Russell Vang; Mamta Gupta; Lee-Shu-Fune Wu; Anna V Yemelyanova; Robert J Kurman; Kathleen M Murphy; Cheryl Descipio; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

4.  Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis for both recently trained and experienced gynecologic pathologists.

Authors:  Mamta Gupta; Russell Vang; Anna V Yemelyanova; Robert J Kurman; Fanghong Rose Li; Emily C Maambo; Kathleen M Murphy; Cheryl DeScipio; Carol B Thompson; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2012-12       Impact factor: 6.394

Review 5.  Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine.

Authors:  Natalia Buza; Pei Hui
Journal:  Mod Pathol       Date:  2021-06-04       Impact factor: 7.842

6.  Refined diagnosis of hydatidiform moles with p57 immunohistochemistry and molecular genotyping: updated analysis of a prospective series of 2217 cases.

Authors:  Deyin Xing; Emily Adams; Jialing Huang; Brigitte M Ronnett
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

7.  Loss of p57 Expression in Conceptions Other Than Complete Hydatidiform Mole: A Case Series With Emphasis on the Etiology, Genetics, and Clinical Significance.

Authors:  Deyin Xing; Karin Miller; Katie Beierl; Brigitte M Ronnett
Journal:  Am J Surg Pathol       Date:  2022-01-01       Impact factor: 6.298

8.  The Diagnosis of Choriocarcinoma in Molar Pregnancies: A Revised Approach in Clinical Testing.

Authors:  Lisa Duffy; Liangtao Zhang; Karen Sheath; Donald R Love; Alice M George
Journal:  J Clin Med Res       Date:  2015-10-23

9.  Paternal Hemizygosity in 11p15 in Mole-like Conceptuses: Two Case Reports.

Authors:  Lone Sunde; Helle Lund; Neil J Sebire; Anni Grove; Rosemary A Fisher; Isa Niemann; Eigil Kjeldsen; Lotte Andreasen; Estrid Staehr Hansen; Anders Bojesen; Lars Bolund; Mette Nyegaard
Journal:  Medicine (Baltimore)       Date:  2015-11       Impact factor: 1.889

10.  Abnormal villous morphology mimicking a hydatidiform mole associated with paternal trisomy of chromosomes 3,7,8 and unipaternal disomy of chromosome 11.

Authors:  Neil J Sebire; Philippa C May; Baljeet Kaur; Michael J Seckl; Rosemary A Fisher
Journal:  Diagn Pathol       Date:  2016-02-04       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.